EMV vs SPL

ASX Healthcare sector comparison — updated 25 Mar 2026 — Healthcare sector

EMV

EMVISION FPO [EMV]

49LOW

SPL

STARPHARMA FPO [SPL]

49LOW

Score Breakdown

EMV SPL
Technical
57
48
Catalyst
55
65
Sentiment
50
50
Fundamental
70
72
Momentum
54
82
Risk Gate
50
50

Key Metrics

EMV Metric SPL
$145.4MMarket Cap$195.3M
41KAvg Volume (20d)1.7M
N/AShort Interest+0.1%
$2.43052-Week High$0.525
$1.52552-Week Low$0.082
+1.0%Daily Change+0.0%
$1.580Entry Price$0.465
-58.0%ROE-14.5%
-188.0%Profit Margin-22.2%

Active Signals

EMV Signals

●RSI drifting toward oversold territory — worth watching
●Trading below both moving averages — the trend is working against this one
●Above-average volume (1.5x) on a green day — buyers stepping up
●Smart money may be accumulating — volume is flowing in even though price hasn't moved yet
●Below the 200-day average — the long-term trend is still working against it
●Adequate cash runway (8 quarters)
●Moderate revenue growth (+11%)
●EPS estimates revised upward (+6pts)

SPL Signals

●Stochastic is stretched into overbought — could need a breather
●Trading above both moving averages — the trend is your friend here
●Watch out — volume is flowing out even as price holds up. Distribution pattern
●Trading above the 200-day average — the long-term trend is on your side
●Strong cash runway (86 quarters)
●Moderate P/S ratio (13.4x)
●Strong revenue growth (+360%)
●EPS estimates revised downward (-10pts)

Ask Scout AI to compare EMV and SPL in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener
EMV Full Analysis → SPL Full Analysis → Healthcare Sector →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).